Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-02-22 @ 9:40 PM
Study NCT ID:
NCT02951767
Status:
COMPLETED
Last Update Posted:
2024-03-28
First Post:
2016-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-31
First Submit QC Date:
None
Study First Post Date:
2016-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-14
Results First Submit QC Date:
None
Results First Post Date:
2017-04-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-01
Last Update Post Date:
2024-03-28
Last Update Post Date Type:
ACTUAL